Viewing Study NCT05014724

Bugs

Ignite Creation Date: 2025-12-18 @ 8:11 AM

Ignite Modification Date: 2025-12-23 @ 10:37 PM

Study NCT ID: NCT05014724

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module